Sun Tong, Chen Siyang, Wu Ke, Sun Min, Zhang Xianyan, You Chao
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.
Health Management Center, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Front Neurol. 2021 Nov 22;12:759221. doi: 10.3389/fneur.2021.759221. eCollection 2021.
Stroke is a leading cause of mortality and morbidity globally. This study aimed to analyze the burden and 30-year trends of ischemic stroke, intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH) in China. Data that include incidence and mortality of stroke in China from January 1, 1990 to December 31, 2019 were derived from the Global Burden of Disease (GBD) study 2019. The absolute numbers of incident cases and deaths over the time, and age-standardized rates per 100,000, such as age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR), were analyzed. In 2019, there were 3.9 (95% uncertainty intervals () 3.4-4.5) million incident cases and 2.1 (3.4-4.5) million deaths related to stroke in China. The ASIR and ASMR of stroke in China was 200 (176-230) and 127 (110-144). From 1990 to 2019, the ASIR of ischemic stroke had increased by 35.0% (29.0-40.0) while the ASIR of ICH and SAH had decreased by -53.0% (-56.0 to -50.0) and by -39.0% (-44.0 to -35.0), respectively. The ASMR of ischemic stroke had increased by 3.0% (-26.0 to 16.0) while the ASMR of ICH and SAH had decreased by -48.0% (-59.0 to -38.0) and by -84.0% (-89.0 to -69.0), respectively. Although the incidence and mortality rates of stroke in China were decreased from 1990 to 2019, the number of incident cases and deaths nearly doubled. A sharp increase in the incidence rate of ischemic stroke was observed. A higher incidence rate of ischemic stroke in the women was also observed.
中风是全球死亡和发病的主要原因。本研究旨在分析中国缺血性中风、脑出血(ICH)和蛛网膜下腔出血(SAH)的负担及30年趋势。1990年1月1日至2019年12月31日期间中国中风发病率和死亡率的数据来源于《2019年全球疾病负担(GBD)研究》。分析了随时间推移的发病病例和死亡的绝对数量,以及每10万人的年龄标准化率,如年龄标准化发病率(ASIR)和年龄标准化死亡率(ASMR)。2019年,中国有390万(95%不确定区间为340万 - 450万)中风发病病例,210万(110万 - 144万)例中风死亡病例。中国中风的ASIR和ASMR分别为200(176 - 230)和127(110 - 144)。1990年至2019年期间,缺血性中风的ASIR上升了35.0%(29.0% - 40.0%),而ICH和SAH的ASIR分别下降了 - 53.0%( - 56.0%至 - 50.0%)和 - 39.0%( - 44.0%至 - 35.0%)。缺血性中风的ASMR上升了3.0%( - 26.0%至16.0%),而ICH和SAH的ASMR分别下降了 - 48.0%( - 59.0%至 - 38.0%)和 - 84.0%( - 89.0%至 - 69.0%)。尽管1990年至2019年中国中风的发病率和死亡率有所下降,但发病病例数和死亡病例数几乎翻了一番。观察到缺血性中风发病率急剧上升。还观察到女性缺血性中风发病率较高。